Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 72

1.

Molecular analyses of cell origin and detection of circulating tumor cells in the peripheral blood in alveolar soft part sarcoma.

Hoshino M, Ogose A, Kawashima H, Izumi T, Hotta T, Hatano H, Morita T, Otsuka H, Umezu H, Yanoma S, Tsukuda M, Endo N.

Cancer Genet Cytogenet. 2009 Apr 15;190(2):75-80. doi: 10.1016/j.cancergencyto.2008.11.014.

PMID:
19380023
2.

Antitumor activity of a combination of trastuzumab (Herceptin) and oral fluoropyrimidine S-1 on human epidermal growth factor receptor 2-overexpressing pancreatic cancer.

Saeki H, Yanoma S, Takemiya S, Sugimasa Y, Akaike M, Yukawa N, Rino Y, Imada T.

Oncol Rep. 2007 Aug;18(2):433-9.

PMID:
17611667
3.

Expression of MMP-7 and MT1-MMP in peritoneal dissemination of gastric cancer.

Yoshikawa T, Yanoma S, Tsuburaya A, Kobayashi O, Sairenji M, Motohashi H, Miyagi Y, Morinaga S, Noguchi Y, Yamamoto Y.

Hepatogastroenterology. 2006 Nov-Dec;53(72):964-7.

PMID:
17153464
4.

Paradoxical discrepancy between the serum level and the placental intensity of PP5/TFPI-2 in preeclampsia and/or intrauterine growth restriction: possible interaction and correlation with glypican-3 hold the key.

Ogawa M, Yanoma S, Nagashima Y, Okamoto N, Ishikawa H, Haruki A, Miyagi E, Takahashi T, Hirahara F, Miyagi Y.

Placenta. 2007 Feb-Mar;28(2-3):224-32. Epub 2006 Mar 31.

PMID:
16580726
5.

Water-generated negative air ions activate NK cell and inhibit carcinogenesis in mice.

Yamada R, Yanoma S, Akaike M, Tsuburaya A, Sugimasa Y, Takemiya S, Motohashi H, Rino Y, Takanashi Y, Imada T.

Cancer Lett. 2006 Aug 8;239(2):190-7. Epub 2005 Sep 19.

PMID:
16171944
6.

Evaluation of soluble adhesion molecules CD44 (CD44st, CD44v5, CD44v6), ICAM-1, and VCAM-1 as tumor markers in head and neck cancer.

Kawano T, Yanoma S, Nakamura Y, Shiono O, Kokatu T, Kubota A, Furukawa M, Tsukuda M.

Am J Otolaryngol. 2005 Sep-Oct;26(5):308-13.

PMID:
16137528
7.

Expression of SPARC in tongue carcinoma of stage II is associated with poor prognosis: an immunohistochemical study of 86 cases.

Kato Y, Nagashima Y, Baba Y, Kawano T, Furukawa M, Kubota A, Yanoma S, Imagawa-Ishiguro Y, Satake K, Taguchi T, Hata R, Mochimatsu I, Aoki I, Kameda Y, Inayama Y, Tsukuda M.

Int J Mol Med. 2005 Aug;16(2):263-8.

PMID:
16012759
8.

The F(ab)'2 fragment of an Abeta-specific monoclonal antibody reduces Abeta deposits in the brain.

Tamura Y, Hamajima K, Matsui K, Yanoma S, Narita M, Tajima N, Xin KQ, Klinman D, Okuda K.

Neurobiol Dis. 2005 Nov;20(2):541-9.

PMID:
15908227
9.

Soluble CD44 standard, CD44 variant 5 and CD44 variant 6 and their relation to staging in head and neck cancer.

Kawano T, Yanoma S, Nakamura Y, Ozeki A, Kokatsu T, Kubota A, Furukawa M, Tsukuda M.

Acta Otolaryngol. 2005 Apr;125(4):392-7.

PMID:
15823810
10.

Induction of lymphokine-activated cytotoxic T lymphocytes stimulated by dendritic cells and autologous tumor from a patient with gastric cancer and their effects in vitro.

Yoshikawa T, Yanoma S, Tsuburaya A, Kobayashi O, Sairenji M, Motohashi H, Noguchi Y.

Hepatogastroenterology. 2005 Jan-Feb;52(61):289-92.

PMID:
15783052
11.

Reovirus oncolysis in human head and neck squamous carcinoma cells.

Ikeda Y, Nishimura G, Yanoma S, Kubota A, Furukawa M, Tsukuda M.

Auris Nasus Larynx. 2004 Dec;31(4):407-12.

PMID:
15571915
12.

Effects of TS-1 on peritoneal dissemination of gastric cancer in nude mice.

Yoshikawa T, Yanoma S, Tsuburaya A, Kobayashi O, Sairenji M, Motohashi H, Hasegawa S, Ishiwa N, Morinaga S, Noguchi Y, Yamamoto Y, Matsumoto A.

Hepatogastroenterology. 2004 Sep-Oct;51(59):1554-7.

PMID:
15362800
13.

Prognostic impact of tissue inhibitor of matrix metalloproteinase-1 in plasma of patients with colorectal cancer.

Yukawa N, Yoshikawa T, Akaike M, Sugimasa Y, Takemiya S, Yanoma S, Imada T, Noguchi Y.

Anticancer Res. 2004 May-Jun;24(3b):2101-5.

14.

Expression of E-cadherin, and CD44s and CD44v6 and its association with prognosis in head and neck cancer.

Kawano T, Nakamura Y, Yanoma S, Kubota A, Furukawa M, Miyagi Y, Tsukuda M.

Auris Nasus Larynx. 2004 Mar;31(1):35-41.

PMID:
15041052
15.

Expression of Epstein-Barr virus in thyroid carcinoma correlates with tumor progression.

Shimakage M, Kawahara K, Sasagawa T, Inoue H, Yutsudo M, Yoshida A, Yanoma S.

Hum Pathol. 2003 Nov;34(11):1170-7.

PMID:
14652819
16.

Inhibition of peritoneal metastasis in an animal gastric cancer model by interferon-gamma and interleukin-2.

Okamoto T, Tsuburaya A, Yanoma S, Yoshikawa T, Cho H, Takanashi Y, Noguchi Y.

Anticancer Res. 2003 Jan-Feb;23(1A):149-53.

PMID:
12680206
17.

Reduction of in vivo tumor growth by MMI-166, a selective matrix metalloproteinase inhibitor, through inhibition of tumor angiogenesis in squamous cell carcinoma cell lines of head and neck.

Katori H, Baba Y, Imagawa Y, Nishimura G, Kagesato Y, Takagi E, Ishii A, Yanoma S, Maekawa R, Yoshioka T, Nagashima Y, Kato Y, Tsukuda M.

Cancer Lett. 2002 Apr 25;178(2):151-9.

PMID:
11867199
18.

Plasma concentration of tissue inhibitor of matrix metalloproteinase 1 in patients with colorectal carcinoma.

Yukawa N, Yoshikawa T, Akaike M, Sugimasa Y, Takemiya S, Yanoma S, Noguchi Y, Takanashi Y.

Br J Surg. 2001 Dec;88(12):1596-601.

PMID:
11736971
19.

The inhibitory effects of TNP470 on tumour growth of head and neck carcinoma cell producing interleukin-8.

Kawano T, Yanoma S, Nishimura G, Tsukuda M.

J Laryngol Otol. 2001 Oct;115(10):802-7.

PMID:
11667992
20.

Intratumoral concentrations of tissue inhibitor of matrix metalloproteinase 1 in patients with gastric carcinoma a new biomartker for invasion and its impact on survival.

Yoshikawa T, Tsuburaya A, Kobayashi O, Sairenji M, Motohashi H, Yanoma S, Noguchi Y.

Cancer. 2001 May 1;91(9):1739-44.

PMID:
11335899
21.

[Induction of apoptosis in breast cancer cells by preoperative oral administration of 5-fluorouracil].

Asaga T, Inaba M, Nagano A, Yanoma S.

Gan To Kagaku Ryoho. 2001 Jan;28(1):49-53. Japanese.

PMID:
11201380
22.

An experimental model of tumor dormancy therapy for advanced head and neck carcinoma.

Nishimura G, Yanoma S, Satake K, Ikeda Y, Taguchi T, Nakamura Y, Hirose F, Tsukuda M.

Jpn J Cancer Res. 2000 Nov;91(11):1199-203.

23.

Therapeutic effect of 1 M tegafur-0.4 M 5-chloro-2, 4-dihydroxypridine-1 M potassium oxonate (S-1) on head and neck squamous carcinoma cells.

Nishimura G, Yanoma S, Mizuno H, Satake K, Taguchi T, Ikeda Y, Tsukuda M.

Cancer Lett. 2000 Oct 16;159(1):1-7.

PMID:
10974399
24.

Six-year disease-free survival of a patient with metastatic eyelid squamous cell carcinoma and colon adenocarcinoma after repeated postoperative adoptive immunotherapy.

Kawamura A Jr, Sekine T, Sekiguchi M, Yanoma S, Kaneko A, Haneda T, Moriya Y, Hayasaka K, Kakizoe T.

Jpn J Clin Oncol. 2000 Jun;30(6):267-71.

PMID:
10939431
25.

Plasma concentrations of VEGF and bFGF in patients with gastric carcinoma.

Yoshikawa T, Tsuburaya A, Kobayashi O, Sairenji M, Motohashi H, Yanoma S, Noguchi Y.

Cancer Lett. 2000 May 29;153(1-2):7-12.

PMID:
10779624
26.

Marked increase of trypsin(ogen) in serum of linitis plastica (gastric cancer, borrmann 4) patients.

Ichikawa Y, Koshikawa N, Hasegawa S, Ishikawa T, Momiyama N, Kunizaki C, Takahashi M, Moriwaki Y, Akiyama H, Yamaoka H, Yanoma S, Tsuburaya A, Nagashima Y, Shimada H, Miyazaki K.

Clin Cancer Res. 2000 Apr;6(4):1385-8.

27.

Therapeutic efficiency of IL-2 gene transduced tumor vaccine for head and neck carcinoma.

Mizuno H, Yanoma S, Nishimura G, Hattori S, Ito T, Okudera K, Tsukuda M.

Cancer Lett. 2000 May 1;152(2):175-85.

PMID:
10773410
28.

Prognostic value of tissue inhibitor of matrix metalloproteinase-1 in plasma of patients with gastric cancer.

Yoshikawa T, Tsuburaya A, Kobayashi O, Sairenji M, Motohashi H, Yanoma S, Noguchi Y.

Cancer Lett. 2000 Apr 3;151(1):81-6.

PMID:
10766426
29.

HIV-DNA vaccination following transfer of a large number of activated T cells enhances immunoresponses against HIV-1.

Hamajima K, Xin KQ, Fukushima J, Yang J, Honsho A, Nakazawa M, Yanoma S, Okuda K.

Viral Immunol. 2000;13(1):3-8. No abstract available.

PMID:
10733163
30.

Angiogenesis inhibitor, TNP-470, suppresses growth of peritoneal disseminating foci.

Yoshikawa T, Yanoma S, Tsuburaya A, Kobayashi O, Sairenji M, Motohashi H, Noguchi Y.

Hepatogastroenterology. 2000 Jan-Feb;47(31):298-302.

PMID:
10690624
31.
32.

Overexpression of laminin gamma2 chain monomer in invading gastric carcinoma cells.

Koshikawa N, Moriyama K, Takamura H, Mizushima H, Nagashima Y, Yanoma S, Miyazaki K.

Cancer Res. 1999 Nov 1;59(21):5596-601.

33.
34.

Tissue inhibitor of matrix metalloproteinase-1 in the plasma of patients with gastric carcinoma. A possible marker for serosal invasion and metastasis.

Yoshikawa T, Saitoh M, Tsuburaya A, Kobayashi O, Sairenji M, Motohashi H, Yanoma S, Noguchi Y.

Cancer. 1999 Nov 15;86(10):1929-35.

PMID:
10570415
35.

[Distribution of lymphocytes to tumor tissue and regional lymph nodes in patients with gastric cancer--the effects of oral administration of OK-432].

Yoshikawa T, Saito M, Tsuburaya A, Kobayashi O, Sairenji M, Motohashi H, Yanoma S, Ono Y.

Gan To Kagaku Ryoho. 1999 Oct;26(12):1813-6. Japanese.

PMID:
10560401
36.

Expression of Epstein-Barr virus in mesopharyngeal and hypopharyngeal carcinomas.

Shimakage M, Sasagawa T, Yoshino K, Yutsudo M, Kimura M, Yamamoto N, Yanoma S.

Hum Pathol. 1999 Sep;30(9):1071-6.

PMID:
10492042
37.

Expression of trypsin in human cancer cell lines and cancer tissues and its tight binding to soluble form of Alzheimer amyloid precursor protein in culture.

Miyata S, Koshikawa N, Higashi S, Miyagi Y, Nagashima Y, Yanoma S, Kato Y, Yasumitsu H, Miyazaki K.

J Biochem. 1999 Jun;125(6):1067-76.

38.

Thymidine phosphorylase/platelet-derived endothelial cell growth factor is upregulated in advanced solid types of gastric cancer.

Yoshikawa T, Suzuki K, Kobayashi O, Sairenji M, Motohashi H, Tsuburaya A, Nakamura Y, Shimizu A, Yanoma S, Noguchi Y.

Br J Cancer. 1999 Mar;79(7-8):1145-50.

39.

Expression of latent and replicative-infection genes of Epstein-Barr virus in macrophage.

Shimakage M, Kimura M, Yanoma S, Ibe M, Yokota S, Tsujino G, Kozuka T, Dezawa T, Tamura S, Ohshima A, Yutsudo M, Hakura A.

Arch Virol. 1999;144(1):157-66.

PMID:
10076516
40.

Combined effect of CDDP and caffeine against human gastric cell line in vivo.

Takahashi M, Yanoma S, Yamamoto Y, Rino Y, Amano T, Imada T.

Anticancer Res. 1998 Nov-Dec;18(6A):4399-401.

PMID:
9891499
41.

[Clinical significance of matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in peripheral blood of patients with gastric carcinoma].

Yoshikawa T, Suzuki K, Kobayashi O, Sairenji M, Motohashi H, Yanoma S, Noguchi Y, Tsuburaya A.

Gan To Kagaku Ryoho. 1998 Jul;25(9):1461-4. Japanese.

PMID:
9703854
42.

[Hepatocyte growth factor (HGF) in fluid from operation fields of breast surgery].

Asaga T, Sugimasa Y, Takemiya S, Suzuki K, Yanoma S.

Gan To Kagaku Ryoho. 1998 May;25(6):834-43. Japanese.

PMID:
9617322
43.

Effect of sublethal total body irradiation on acute graft-versus-host disease and graft-versus-leukemia effect in SCID mice.

Sakai R, Maruta A, Yanoma S, Shimizu A, Harada M, Nakamura Y, Kodama F, Okubo T.

Bone Marrow Transplant. 1997 Aug;20(3):183-9.

44.

Expression of trypsin in vascular endothelial cells.

Koshikawa N, Nagashima Y, Miyagi Y, Mizushima H, Yanoma S, Yasumitsu H, Miyazaki K.

FEBS Lett. 1997 Jun 16;409(3):442-8.

45.

Analysis of DNA ploidy using fresh frozen tissues of head and neck squamous cell carcinomas.

Arai Y, Tsukuda M, Ito K, Enomoto H, Furukawa M, Kubota A, Yanoma S, Okamoto N.

Auris Nasus Larynx. 1997 Apr;24(2):193-8.

PMID:
9134143
46.
47.

[In vitro chemosensitivity test for seven undifferentiated thyroid carcinoma cell lines using MTT assay].

Osawa Y, Yoshida A, Asaga T, Kawahara S, Yanoma S.

Gan To Kagaku Ryoho. 1996 Mar;23(4):471-6. Japanese.

PMID:
8678500
48.

HLA A2601-restricted CTLs recognize a peptide antigen expressed on squamous cell carcinoma.

Nakao M, Yamana H, Imai Y, Toh Y, Toh U, Kimura A, Yanoma S, Kakegawa T, Itoh K.

Cancer Res. 1995 Oct 1;55(19):4248-52.

49.

Production of cytokines by thyroid carcinoma cell lines.

Yoshida A, Asaga T, Masuzawa C, Kawahara S, Yanoma S, Harada M, Okamoto T.

J Surg Oncol. 1994 Feb;55(2):104-7.

PMID:
8121182
50.

[The growth activity and DNA ploidy in anaplastic carcinoma transplanted to nude mice].

Yoshida A, Asaga T, Masuzawa C, Kawahara S, Yanoma S, Shimizu A, Harada M.

Nihon Geka Gakkai Zasshi. 1993 Feb;94(2):177-81. Japanese.

PMID:
8464414

Supplemental Content

Loading ...
Support Center